Glioma

A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. Read More

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read More

A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding. Read More